Virus-induced autoimmunity

Reviews of Infectious Diseases

Volumn 12, Issue 2, 1990, Pages 204-222

  Schattner, Amichai ^a,b,c,d   Rager Zisman, Bracha ^a,b,c,d  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b KAPLAN HOSPITAL   (Israel)

^c HEBREW UNIVERSITY   (Israel)

^d BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

AUTOIMMUNITY; ETIOLOGY; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; VIRUS INFECTION; VIRUS PATHOGENESIS;

ANIMAL; ANTIBODIES, VIRAL; AUTOANTIBODIES; AUTOIMMUNE DISEASES; DISEASE MODELS, ANIMAL; HUMAN; VIRUS DISEASES;

EID: 0025253773     PISSN: 01620886     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/12.2.204     Document Type: Article

References (209)

1. Shoenfeld Y, Schwartz RS. Immunologic and genetic factors in autoimmune diseases. N Engl J Med 1984;311: 1019–29
2. Clyde WA Jr., Thomas L. Pathogenesis studies in experimental mycoplasma disease: M. gallisepticum infections of turkeys. Ann NY Acad Sci 1973;225:413–24
3. Kuzumaki N, Kodama T, Takeichi N, Kobayashi H. Friendlymphatic leukemia virus–induced autoimmune hemolytic anemia with glomerulonephritis in the rat. Int J Cancer 1974;14:483–92
4. Hirsch MS, Proffitt MR. Autoimmunity in viral infections.In: Notkins AL, ed. Viral immunology and immunopathology. New York: Acadmic Press, 1975:419–34
5. Theofilopoulos AN, Dixon FJ. Murine models of systemiclupus erythematosus. Adv Immunol 1985;37:269–390
6. Adams DD. A theory of the pathogenesis of rheumatic fever, glomerulonephritis and other autoimmune diseases triggered by infection. Clin Exp Immunol 1969;5:105–15
7. Williams RC Jr. Infection and autoimmunity. In: Talal N, ed. Autoimmunity: genetic, immunologic, virologic and clinical aspects. New York: Academic Press, 1977:457–79
8. Schooley RT, Densen P, Harmon D, Felsenstein D, Hirsch MS, Henle WE, Weitzman S. Antineutrophil antibodies in infectious mononucleosis. Am J Med 1984;76:85–90
9. Misra R, Venables PJW, Plater-Zyberk C, Watkins PF, Maini RN. Anti–cardiolipin antibodies in infectious mononucleosis react with the membrane of activated lymphocytes. Clin Exp Immunol 1989;75:35–40
10. Toh BH, Yildiz A, Sotelo J, Osung O, Holborow EJ, Kanak-oudi F, Small JV. Viral infections and IgM autoantibodies to cytoplasmic intermediate filaments. Clin Exp Immunol 1979;37:76–82
11. Andersen P, Andersen HK. Smooth–muscle antibodies and other tissue antibodies in cytomegalovirus infection. Clin Exp Immunol 1975;22:22–9
12. Vento S, McFarlane BM, McSorley CG, Ranieri S, Giuliani-Piccari G, Dal Monte PR, Verucchi G, Williams R, Chiodo F, McFarlane IG. Liver autoreactivity in acute virus A, B and non–A, non–B hepatitis. J Clin Lab Immunol 1988;25:1–7
13. Portocala R, Spyrou N, Lambropoulou V, Pateraki E. Presence of both virus–specific and autoantibodies in the sera from patients with adenovirus and influenza B. Proceedings of the 7th European Immunology Meeting; Jerusalem, 1985
14. Maisch B, Trostel-Soeder R, Stechemesser E, Berg PA, Koch-siek KK. Diagnostic relevance of humoral and cell–mediated immune reactions in patients with acute viral myocarditis. Clin Exp Immunol 1982;48:533–45
15. Bodansky HJ, Grant PJ, Dean BM, McNally J, BottazzoGF, Hambling MH, Wales JK. Islet–cell antibodies and insulin autoantibodies in association with common viral infections. Lancet 1986;2:1351–3
16. Kopelman RG, Zola-Pazner S. Association of human immunodeficiency virus infection and autoimmune phenomena. Am J Med 1988;84:82–8
17. Schattner A. The origin of autoantibodies. Immunology Lett 1987;14:143–53
18. Maisch B, Deeg P, Liebau G, Kochsiek K. Diagnostic relevance of humoral and cytotoxic immune reactions in primary and secondary dilated cardiomyopathy. Am J Cardiol 1983;52:1072–8
19. Vento S, Eddleston A.L.W.F. Immunological aspects of chronic active hepatitis. Clin Exp Immunol 1987;68:225–32
20. Jensen DM, McFarlane IG, Portmann BS, Eddleston ALWF, Williams R. Detection of antibodies directed against a liver–specific membrane lipoprotein in patients with acute and chronic active hepatitis. N Engl J Med 1978;299:1–7
21. Karam JH, Prosser PR, LeWitt PA. Islet–cell surface antibodies in a patient with diabetes mellitus after rodenticide ingestion [letter]. N Engl J Med 1978;299:1191
22. Rose NR, Herskowitz A, Neumann DA, Neu N. Autoimmune myocarditis: a paradigm of post–infection autoimmune disease. Immunol Today 1988;9:117–20
23. Schattner A, Shani A, Talpaz M, Benttwich Z. Rheumatoid factors in the sera of patients with gastrointestinal carcinoma. Cancer 1983;52:2156–61
24. Banatvala JE. Insulin–dependent (juvenile–onset, type 1) diabetes mellitus. Coxsackie B viruses revisited. Prog Med Virol 1987;34:33–54
25. Eisenbarth GS. Type I diabetes mellitus: a chronic autoimmune disease. N Engl J Med 1986;314:1360–8
26. Notkins AL, Yoon J-W. Virus–induced diabetes mellitus. In: Notkins AL, Oldstone MBA, eds. Concepts in viral pathogenesis. New York: Springer Verlag, 1984:241–7
27. Cheeseman SH. Infectious mononucleosis. Semin Hematol 1988;25:261–8
28. Whittingham S, McNeilage J, Mackay IR. Primary Sjogren’s syndrome after infectious mononucleosis. Ann Intern Med 1985;102:490–3
29. Baranski B, Armstrong G, Truman JT, Quinnan GV Jr., Straus SE, Young NS. Epstein–Barr virus in the bone marrow of patients with aplastic anemia. Ann Intern Med 1988;109:695–704
30. Hart IK, Kennedy P.G.E. Guillain–Barre syndrome associated with cytomegalovirus infection. Quart J Med 1988;67: 425–30
31. Inman RD. Rheumatic manifestations of hepatitis B virus infection. Semin Arthritis Rheum 1982;11:406–20
32. Inman RD, Hodge M, Johnston MEA, Wright J, Heath-cote J. Arthritis, vasculitis, and cryoglobulinemia associated with relapsing hepatitis A virus infection. Ann Intern Med 1986;105:700–3
33. Sibley WA, Bamford CR, Clark K. Clinical viral infections and multiple sclerosis. Lancet 1985;1:1313–5
34. Anonymous. Guillain–Barre syndrome [editorial]. Lancet 1988;2:659–61
35. De Vere-Tyndall A, Bacon T, Parry R, Tyrrell DAJ, Denman AM, Ansell BM. Infection and interferon production in systemic juvenile chronic arthritis: a prospective study. Ann Rheum Dis 1984;43:1–7
36. Aster RH. Thrombocytopenia due to enhanced platelet destruction. In: Williams WJ, Beutler E, Erslev AJ, Rundles RW, eds. Hematology. 2nd ed. New York: McGraw–Hill, 1977:1326–60
37. Rossini AA, Mordes JP, Like AA. Immunology of insulin-dependent diabetes mellitus. Annu Rev Immunol 1985; 3:289–320
38. Bellanti JA. Adverse effects of viral vaccines. In: Notkins AL, ed. Viral immunology and immunopathology. New York: Academic Press, 1975:327–39
39. Grose C, Spigland I. Guillain–Barre syndrome following administration of live measles vaccine. Am J Med 1976;60: 441–3
40. Wolinsky JS. Central nervous system complications of viral infections and vaccines. In: Wyngaarden JB, Smith LH Jr, eds. Cecil textbook of medicine. 18th ed. Philadelphia: W. B. Saunders, 1988:2208–9
41. Fried M, Conen D, Conzelmann M, Steinmann E. Uveitis after hepatitis B vaccination [letter]. Lancet 1987;2:631–2
42. Biron P, Montpetit P, Infante-Rivard C, Lery L. Myasthenia gravis after general anesthesia and hepatitis B vaccine. Arch Intern Med 1988;148:2685
43. Patel U, Bradley JR, Hamilton DV. Henoch–Schonlein purpura after influenza vaccination [letter]. Br Med J 1988;296:1800
44. Williams GW, Steinberg AD, Reinertsen JL, Klassen LW, Decker JL, Dolin R. Influenza immunization in systemic lupus erythematosus. A double blind trial. Ann Intern Med 1978;88:729–34
45. Truner-Stokes L, Isenberg DA. Immunisation of patients with rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis 1988;47:529–31
46. Onodera T, Toniolo A, Ray UR, Jenson AA, Knazek RA, Notkins AL. Virus–induced diabetes mellitus. XX. Polyendocrinopathy and autoimmunity. J Exp Med 1981; 153:1547–73
47. Onodera T, Ray UR, Melez KA, Suzuki H, Toniolo A, Notkins AL. Virus–induced diabetes mellitus: autoimmunity and polyendocrine disease prevented by immunosuppression. Nature 1982;297:66–8
48. Haspel MVT, Onodera T, Prabhakar BS, Horita M, Suzuki H, Notkins AL. Virus–induced autoimmunity: monoclonal antibodies that react with endocrine tissues. Science 1983;220:304–6
49. Jordan GW, Cohen SH. Encephalomyocarditis virus–induced diabetes mellitus in mice: model of viral pathogenesis. Rev Infect Dis 1987;9:917–24
50. Adams TE, Alpert S, Hanahan D. Non–tolerance and autoantibodies to a transgenic self antigen expressed in pancreatic P cells. Nature 1987;325:223–8
51. Wolfgram LJ, Beisel KW, Rose NR. Heart–specific autoantibodies following murine coxsackievirus B3 myocarditis. J Exp Med 1985;161:1112–21
52. Wong CY, Woodruff JJ, Woodruff JF. Generation of cytotoxic T lymphocytes during coxsackievirus B–3 infection. Characterization of effector cells and demonstration of cytotoxicity against viral–infected myofibers. J Immunol 1977;118:1165–9
53. Huber SA, Lodge PA. Coxsackievirus B–3 myocarditis in BALB/c mice. Evidence for autoimmunity to myocyte antigens. Am J Pathol 1984;116:21–9
54. Ytterberg SR. Coxsackievirus B1–induced murine polymyositis: acute infection with active virus is required for myositis. J Rheumatol 1987;14:12–8
55. Ytterberg SR, Mahowald ML, Messner RP. Coxsackievirus B1–induced polymyositis. Lack of disease expression in nu/nu mice. J Clin Invest 1987;80:499–506
56. Miller FW, Love LA, Biswas T, McClintock PR, Notkins AL, Plotz PH. Viral and host genetic factors influence encephalomyocarditis virus–induced polymyositis in adult mice. Arthritis Rheum 1987;30:549–56
57. Ohara Y, Roos R. The antibody response in Theiler’s virus infection: new perspectives on multiple sclerosis. Prog Med Virol 1987;34:156–79
58. Oldstone M.B.A. Virus–induced immune complex formation and disease: definition, regulation, importance. In: Notkins AL, Oldstone MBA, eds. Concepts in viral pathogenesis. New York: Springer–Verlag, 1984:201–9
59. Oldstone M.B.A. Virus neutralization and virus–induced immune complex disease: virus–antibody union resulting in immunoprotection or immunologic injury–two sides of the same coin. Prog Med Virol 1975;19:84–119
60. Notkins AL, Mahar S, Schelle C, Goffman J. Infectious virus–antibody complex in the blood of chronically infected mice. J Exp Med 1966;124:81–98
61. Porter DD. Aleutian disease: a persistent parvovirus infection of mink with a maximal but ineffective host humoral immune response. Prog Med Virol 1986;33:42–60
62. Marion PL. Use of animal models to study hepatitis B virus. Prog Med Virol 1988;35:43–75
63. Henson JB, McGuire TC. Equine infectious anemia. Prog Med Virol 1974;18:143–59
64. McGuire TC. Retrovirus–induced arthritis. In: Notkins AL, Oldstone MBA, eds. Concepts in viral pathogenesis. New York: Springer–Verlag, 1984:254–9
65. Smith HR, Steinberg AD. Autoimmunity-a perspective. Annu Rev Immunol 1983;1:175–210
66. Oldstone M.B.A., Southern P, Rodriguez M. Lampert P. Virus persists in (3 cells and islets of Langerhans and is associated with chemical manifestations of diabetes. Science 1984;224:1440–3
67. Mordes JP, Rossini AA. Animal models of diabetes. Am J Med 1981;70:353–60
68. Gresser I. Can interferon induce disease? In: Gresser I, ed. Interferon 1982. Vol. 4. New York: Academic Press, 1982:95–127
69. Haspel MV, Onodera T, Prabhaker BS, McClintock PR, Es-sani K, Ray UR, Yagihashi S, Notkins AL. Multiple organreactive monoclonal autoantibodies. Nature 1983;304: 73–6
70. Satoh J, Prabhakar BS, Haspel MV, Ginsberg-Fellner F, Notkins AL. Human monoclonal autoantibodies that react with multiple endocrine organs. N Engl J Med 1983; 309:217–20
71. Anonymous. Do T cells cause IDDM? [editorial] Lancet 1988;2:661–2
72. Gonatas NK, Greene MI, Waksman BH. Genetic and molecular aspects of demyelination. Immunol Today 1986; 7:121–6
73. Ellison GW, moderator. Multiple sclerosis [discussion]. Ann Intern Med 1984;101:514–6
74. Neu N, Tose NR, Beisel KW, Herskowitz A, Gurri-Glass G, Craig SW. Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 1987;139:3630–6
75. Alvarez FL, Neu N, Rose NR, Craig SW, Beisel KW. Heart–specific autoantibodies induced by coxsackievirus B3: identification of heart autoantigens. Clin Immunol Immunopathol 1987;43:129–39
76. London WT. Hepatitis B virus and antigen-antibody complex diseases [editorial], N Engl J Med 1977;296:1528–9
77. Cooper NR, Nemerow GR. Complement, viruses, and virus–infected cells. Springer Semin Immunopathol 1983;6: 327–47
78. Lutton CW, Gauntt CJ. Ameliorating effect of IFN–β and anti–IFN–β on coxsackievirus B3–induced myocarditis in mice. J Interferon Res 1985;5:137–46
79. Fagraeus A, Orvell C, Norberg R, Norrby E. Monoclonal antibodies to epitopes shared by actin and vimentin obtained by paramyxovirus immunization. Exp Cell Res 1983;145:425–32
80. Dales S, Fujinami RS, Oldstone M.B.A. Infection with vaccinia favors the selection of hybridomas synthesizing autoantibodies against intermediate filaments, one of them cross-reacting with the virus hemagglutinin. J Immunol 1983;131:1546–53
81. Oldstone M.B.A. Molecular mimicry and autoimmune disease. Cell 1987;50:819–20
82. Srinivasappa J, Saegusa J, Prabhakar BS, Gentry MK, Buch-meier MJ, Wiktor TJ, Koprowski H, Oldstone MBA, Notkins AL. Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues. J Virol 1986;57:397–401
83. Oldstone M.B.A. Molecular anatomy of viral disease. The George Cotzias Memorial Lecture 1986. Neurology 1987; 37:453–60
84. Mims CA. Interactions of viruses with the immune system. Clin Exp Immunol 1986;66:1–16
85. McChesney MB, Oldstone M.B.A. Viruses perturb lymphocyte functions: selected principles characterizing virus–induced immunosuppression. Annu Rev Immunol 1987; 5:279–304
86. Steinberg AD. Immunology: aetiology of autoimmunity. Nature 1983:304:20
87. Tosato G, Blaese RM. Epstein–Barr virus infection and immunoregulation in man. Adv Immunol 1985;37:99–149
88. Garzelli C, Taub FE, Scharff JE, Prabhakar BS, Gisnberg-Fellner F, Notkins AL. Epstein–Barr virus–transformed lymphocytes produce monoclonal autoantibodies that react with antigens in multiple organs. J Virol 1984;52:722–5
89. Yachie A, Tosato G, Straus SE, Blaese RM. Immunostimulation by cytomegalovirus (CMV): helper T cell–dependent activation of immunoglobulin production in vitro by lymphocytes from CMV–immune donors. J Immunol 1985; 135:1395–1400
90. Schnittman SM, Lane HC, Higgins SE, Folks T, Fauci AS.Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus. Science 1986;233:1084–6
91. Miller KB, Schwartz RS. Autoimmunity and suppressor Tlymphocytes. Adv Intern Med 1982;27:281–313
92. Topliss D, How J, Lewis M, Row V, Volpe R. Evidence for cell–mediated immunity and specific suppressor T lymphocyte dysfunction in Graves’ disease and diabetes mellitus. J Clin Endocrinol Metab 1983;57:700–5
93. Vento S, Hegarty JE, Bottazzo G, Macchia E, Williams R, Eddleston A.L.W.F. Antigen specific suppressor cell function in autoimmune chronic active hepatitis. Lancet 1984;1:1200–4
94. Ahmed R, Oldstone M.B.A. Mechanisms and biological implications of virus–induced polyclonal B–cell activation. In: Notkins AL, Oldstone MBS, eds. Concepts in viral pathogenesis. New York: Springer–Verlag, 1984:231–8
95. DeHoratius RJ. Lymphocytotoxic antibodies. Prog Clin Immunol 1980;4:151–74
96. Malave I, Papa R, Layrisse Z. Lymphocytotoxic antibodies in SLE patients and their relatives. Arthritis Rheum 1976;19:700–4
97. Warren RQ, Johnson EA, Donnelly RP, Lavia MF, Tsang KY. Specificity of anti–lymphocyte antibodies in sera from patients with AIDS–related complex (ARC) and healthy homosexuals. Clin Exp Immunol 1988;73:168–73
98. Morimoto C, Reinherz EL, Distaso JA, Steinberg AD, Schlossman SF. Relationship between systemic lupus erythematosus T cell subsets, anti–T cell antibodies, and T cell functions. J Clin Invest 1984;73:689–700
99. Strieker RB, McHugh TM, Moody DJ, Morrow W.J.W., Stittes DP, Shuman MA, Levy JA. An AIDS–related cytotoxic autoantibody reacts with a specific antigen on stimulated CD4* T cells [letter]. Nature 1987;327:710–3
100. Gastl G, Niederwieser D, Marth C, Huber H, Egg D, Schuler G, Margreiter R, Braunsteiner H, Huber C. Human large granular lymphocytes and their relationship to natural killer cell activity in various disease states. Blood 1984; 64:288–95
101. Harris DT, Cianciolo GJ, Snyderman R, Argov S, Koren HS. Inhibition of human natural killer cell activity by a synthetic peptide homologous to a conserved region in the retroviral protein, pl5E. J Immunol 1987;138:889–94
102. Schattner A. Interferons and autoimmunity. Am J Med Sci 1988;295:532–44
103. Abruzzo LV, Rowley DA. Homeostasis of the antibody response: immunoregulation by NK cells. Science 1983; 222:581–5
104. Schattner A, Duggan DB. Natural killer cells and the pathogenesis of systemic lupus erythematosus [letter]. Arthritis Rheum 1984;27:1072–3
105. Morris AG, Lin Y-L, Askonas BA. Immune interferon release when a cloned cytotoxic T–cell line meets its correct influenza-infected target cell. Naure 1982;295:150–2
106. Frei K, Leist TP, Meager A, Gallo P, Leppert D, Zinker-nagel RM, Fontana A. Production of B cell stimulatory factor–2 and interferon y in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients. J Exp Med 1988;168:449–53
107. Wong GHW, Goeddel DV. Thmour necrosis factors α and β inhibit virus replication and synergize with interferons [letter]. Nature 1986;323:819–22
108. Beutler B. The presence of cachectin/tumor necrosis factor in human disease states [editorial]. Am J Med 1988; 85:287–8
109. Doherty PC. Some problem areas in the interaction between viruses and the immune system. Immunol Cell Biol 1987;65:279–86
110. Klein J. Natural history of the major histocompatibility complex. New York: John Wiley & Sons, 1986:453–5
111. Campbell IL, Harrison LC, Ashcroft RG, Jack I. Reovirus infection enhances expression of class I MHC proteins on human beta–cell and rat (RINm 5F) cells. Diabetes 1988;37:362–5
112. Feldman M, Londei M, Buchan G. Interferons and autoimmunity. In: Gresser I, ed. Interferon 9. New York: Academic Press, 1987:75–90
113. Massa PT, Dorries R, ter Meulen V. Viral particles induce la antigen expression on astrocytes [letter]. Nature 1986;320:543–6
114. Feldman M. Regulation of HLA class II expression and its role in ATID. In: Autoimmunity and autoimmune diseases. Ciba Foundation Symposium. Vol. 129. Chichester, UK: John Wiley & Sons, 1987:88–108
115. Massa PT, Schimpl A, Wecker E, ter Meulen V. Hunor necrosis factor amplifies measles virus–mediated la induction on astrocytes. Proc Natl Acad Sci USA 1987;84:7242–5
116. Pujol-Borrell R, Todd I, Doshi M, Bottazo GF, Sutton R, Gray D, Adolf GR, Feldmann M. HLA class II induction in human islet cells by interferon–γ plus tumour necrosis factor or lymphotoxin [letter]. Nature 1987;326:304–6
117. Bottazzo GF, Pujol-Borrell R, Hanafusa T, Feldmann M. Role of aberrant HLA–DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 1983;2:1115–9
118. Allison J, Campbell IL, Morahan G, Mandel TE, Harrison LC, Miller J.F.A.P. Diabetes in transgenic mice resulting from over–expression of class I histocompatibility molecules in pancreatic β cells. Nature 1988;333:529–33
119. Lo D, Burkly LC, Widera G, Cowing C, Flavell RA, Palmiter RD, Brinster RL. Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cells. Cell 1988;53:159–68
120. Sarvetnick N, Liggitt D, Pitts SL, Hansen SE, Stewart TA. Insulin–dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferongamma. Cell 1988;52:773–82
121. Pujol-Borrell R, Bottazzo GF. Puzzling diabetic transgenic mice: a lesson for human type 1 diabetes? Immunol Today 1988;9:303–6
122. Esparza I, Fox RI, Schreiber RD. Interferon–γ–dependent modulation of C3b receptors (CR1) on human peripheral blood monocytes. J Immunol 1986;136:1360–5
123. Yefenof E, McConnell I. Interferon amplifies complement activation by Burkitt’s lymphoma cells [letter]. Nature 1985;313:684–5
124. Sibbitt WL Jr., Gibbs DL, Kenny C, Bankhurst AD, Searles RP, Ley KD. Relationship between circulating interferon and anti–interferon antibodies and impaired natural killer cell activity in systemic lupus erythematosus. Arthritis Rheum 1985;28:624–9
125. Fradelizi D, Gresser I. Interferon inhibits the generation of allospecific suppressor T lymphocytes. J Exp Med 1982; 155:1610–22
126. Frasca D, Adorini L, Landolfo S, Doria G. Enhancement of suppressor T cell activity by injection of anti–IFN–γ monoclonal antibody. J Immunol 1988;140:4103–7
127. Schattner A, Duggan D, Naparstek Y, Schwartz RS. Effects of interferon–α on the expression of a lupus idiotype in normal humans. Clin Immunol Immunopathol 1986; 38:327–36
128. Foulis AK, Farquharson MA, Meager A. Immunoreactive α–interferon in insulin–secreting β cells in type 1 diabetes mellitus. Lancet 1987;2:1423–7
129. Hopkins SJ, Meager A. Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon. Clin Exp Immunol 1988;73:88–92
130. Zoumbos NC, Gascón P, Djeu JY, Trost SR, Young NS. Circulating activated suppressor T lymphocytes in aplastic anemia. N Engl J Med 1985;319:257–65
131. Preble OT, Black RJ, Friedman RM, Klippel JH, Vilcek J. Systemic lupus erythematosus: presence in human serum of an unusual acid–labile leukocyte interferon. Science 1982;216:429–31
132. DeStefano E, Friedman RM, Friedman-Kien AE, Goedert JJ, Henriksen D, Preble OT, Sonnabend JA, Vildek J. Acid–labile human leukocyte interferon in homosexual men with Kaposi’s sarcoma and lymphadenopathy. J Infect Dis 1982;146:451–5
133. Fujinami RS, Oldstone MBA, Wroblewska Z, Frankel ME, Koprowski H. Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci USA 1983;80:2346–50
134. Bahmanyar S, Srinivasappa J, Casali P, Fujinami RS, Oldstone MBA, Notkins AL. Antigenic mimicry between measles virus and human T lymphocytes [letter]. J Infect Dis 1987;156:526–7
135. Casali P, Rice GPA, Oldstone M.B.A. Viruses disrupt functions of human lymphocytes. Effects of measles virus and influenza virus on lymphocyte–mediated killing and antibody production. J Exp Med 1984;159:1322–37
136. Rhodes G, Rumpold H, Kurki P, Patrick KM, Carson DA, Vaughan JH. Autoantibodies in infectious mononucleosis have specificity for the glycine–alanine repeating region of the Epstein–Barr virus nuclear antigen. J Exp Med 1987;165:1026–40
137. Fox R, Sportsman R, Rhodes G, Luka J, Pearson G, Vaughan J. Rheumatoid arthritis synovial membrane contains a 62, 000–molecular–weight protein that shares an antigenic epitope with the Epstein–Barr virus–encoded associated nuclear antigen. J Clin Invest 1986;77:1539–47
138. gag antigen. Cell 1987;51:211–20
139. Weise MJ, Carnegie PR. An approach to searching protein sequences for superfamily relationships or chance similarities relevant to the molecular mimicry hypothesis: application to the basic proteins of myelin. J Neurochem 1988;51:1267–73
140. 1 domain. I. Monoclonal antibodies against the gp41–derived peptide and patients’ sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome. J Exp Med 1988;167:914–23
141. Roudier J, Rhodes G, Petersen J, Vaughan JH, Carson DA. The Epstein–Barr virus glycoprotein gp110, a molecular link between HLA DR4, HLA DR1, and rheumatoid arthritis. Scand J Immunol 1988;27:367–71
142. Fujinami RS, Oldstone M.B.A. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science 1985; 230:1043–5
143. Kagnoff MF, Paterson YJ, Kumar PJ, Kasarda DD, Carbone FR, Unsworth DJ, Austin RK. Evidence for the role of a human intestinal adenovirus in the pathogenesis of coeliac disease. Gut 1987;28:995–1001
144. Walker EJ, Jeffrey PD. Polymyositis and molecular mimicry, a mechanism of autoimmunity. Lancet 1986;2:605–7
145. Tan EM. Antinuclear antibodies: diagnostic markets for autoimmune diseases and probes for cell biology. Adv Immunol 1989;44:93–153
146. Plotz PH. Autoantibodies are anti-idiotype antibodies to antiviral antibodies. Lancet 1983;2:824–6
147. Cooke A, Lydyard PM, Roitt IM. Autoimmunity and idio-types. Lancet 1984;2:723–5
148. Nepom JT, Weiner HL, Dichter MA, Tardieu M, Spriggs DR, Gramm CF, Powers ML, Fields BN, Greene MI. Identification of a hemagglutinin–specific idiotype associated with reovirus recognition shared by lymphoid and neural cells. J Exp Med 1982;155:155–167
149. Mouritsen S. Rheumatoid factors are anti-idiotypic antibodies against virus–induced anti–Fc receptor antibodies. A hypothesis for the induction of some rheumatoid factors [editorial]. Scand J Immunol 1986;24:485–90
150. Bruck C, Co MS, Slaoui M, Gaulton GN, Smith T, Fields BN, Mullins JI, Greene ML Nucleic acid sequence of an internal image–bearing monoclonal anti–idiotype and its comparison to the sequence of the external antigen. Proc Natl Acad Sci USA 1986;83:6578–82
151. Notkins AL, Onodera T, Prabhakar B. Virus–induced autoimmunity. In: Notkins AL, Oldstone MBA, eds. Concepts in viral pathogenesis. New York: Springer Verlag, 1984:210–5
152. Cooke A, Lydyard PM, Roitt IM. Mechanisms of autoimmunity: a role of cross-reactive idiotypes. Immunol Today 1983;4:170–5
153. Lutton CW, Gauntt CJ. Coxsackievirus B3 infection alters plasma membrane of neonatal skin fibroblasts. J Virol 1986;60:294–6
154. Bennink JR, Yewdell JW, Gerhard W. A viral polymerase involved in recognition of influenza virus–infected cells by a cytotoxic T–cell clone. Nature 1982;296:75–6
155. Grau GE, Morrow D, Izui S, Lambert PH. Pathogenesis of the delayed phase of Rauscher virus–induced thrombocytopenia. J Immunol 1986;136:686–91
156. Mathews MB, Bernstein RM. Myositis autoantibody inhibits histidyl–tRNA synthetase: a model for autoimmunity [letter]. Nature 1983;304:177–9
157. Nakamura M, Burastero SE, Ueki Y, Larrick JW, Notkins AL, Casali P. Probing the normal and autoimmune B cell repertoire with Epstein–Barr virus. J Immunol 1988; 141:4165–72
158. Anonymous. The viral aetiology of rheumatoid arthritis [editorial]. Lancet 1984;1:772–4
159. Jordan MC, moderator. Latent herpesviruses of humans. Ann Intern Med 1984;100:866–80
160. Pelton BK, North M, Palmer RG, Hylton W, Smith-Burchnell C, Sinclair AL, Malkovsky M, Dalgleish AG, Denman AM. A search for retrovirus infection in systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 1988;47:206–9
161. Waksman B. Mechanisms in multiple sclerosis. Nature 1985;318:104–5
162. Kurtzke JF, Hyllested K. Multiple sclerosis in the Faroe Islands: I. Clinical and epidemiological features. Ann Neurol 1979;5:6–21
163. Norrby E, Link H, Olsson J-E, Panelius M, Salmi A, Vandvik B. Comparison of antibodies against different viruses in cerebrospinal fluid and serum samples from patients with multiple sclerosis. Infect Immun 1974;10:688–94
164. Goswami K.K.A., Randall RE, Lange LS, Russell WC. Antibodies against the paramyxovirus SV5 in the cerebrospinal fluids of some multiple sclerosis patients [letter]. Nature 1987;327:244–7
165. Greenstein JI, McFarland HF, Richert JR. Characterization of antigen–specific T cells in multiple sclerosis twins with elevated proliferative responses to measles virus. J Immunol 1986;137:546–50
166. Koprowski H, DeFreitas EC, Harper ME, Sandberg-Wollheim M, Sheremata WA, Robert-Guroff M, Saxinger CW, Feinberg MB, Wong-Staal F, Gallo RC. Multiple sclerosis and human T-cell lymphotropic retroviruses. Nature 1985;318:154–60
167. Knobler RL, Panitch HS, Braheny SL, Sipe JC, Rice GPA, Huddlestone JR, Francis GS, Hoper CJ, Kamin-Lewis RM, Johnson KP, Oldstone MBA, Merigan TC. Systemic alpha–interferon therapy of multiple sclerosis. Neurology 1984;34:1273–9
168. Jacobs L, Salazar AM, Herndon R, Reese PA, Freeman A, Josefowicz R, Cuetter A, Husain F, Smith WA, Ekes R, O’Malley JA. Multicentre double–blind study of effect of intrathecally administered natural human fibroblast interferon on exacerbations of multiple sclerosis. Lancet 1986;2:1411–3
169. King ML, Bidwell D, Voller A, Bryant J, Banatvala JE. Role of coxsackie B viruses in insulin-dependent diabetes mellitus [letter]. Lancet 1983;2:915–6
170. Frisk G, Fohlman J, Kobbah M, Ewald U, Tuvemo T, Diderholm H, Friman G. High frequency of coxsackie–B–virus–specific IgM in children developing type I diabetes during a period of high diabetes morbidity. J Med Virol 1985;17:219–27
171. Schemthaner G, Banatvala JE, Scherbaum W, Bryant J, Bur-kenstein M, Schober E, Mayer WR. Coxsackie–B–virus–specific IgM responses, complement–fixing islet–cell antibodies, HLA DR antigens, and c–peptide secretion in insulin–dependent diabetes mellitus. Lancet 1985;2:630–2
172. Pak CY, Eun H-M, McArthur RG, Yoon J-W. Association of cytomegalovirus infection with autoimmune type 1 diabetes. Lancet 1988;2:1–4
173. Robertson D.A.F., Zhang SL, Guy EC, Wright R. Persistent measles virus genome in autoimmune chronic active hepatitis. Lancet 1987;2:9–11
174. Bowles NE, Richardson PJ, Olsen E.G.J., Archard LC. Detection of coxsackie–B–virus–specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1986;1:1120–3
175. Bowles NE, Dubowitz V, Sewry CA, Archard LC. Dermatomyositis, polymyositis, and coxsackie–B–virus infection. Lancet 1987;1:1004–7
176. Eglin RP, Lehner T, Subak-Sharpe JH. Detection of RNA complementary to herpes simplex virus in mononuclear cells from patients with Behcet’s syndrome and recurrent oral ulcers. Lancet 1982;2:1356–61
177. Hussain L, Ward R, Lehner T, Barnes CG. Herpes simplex virus IgG, IgM and IgG subclass from sera of patients with Behcet’s disease and controls. In: Lehner T, Barnes CG, eds. Recent advances in Behcet’s disease. London: Royal Society of Medicine, 1986:73–82
178. Denman AM, Fialkow PJ, Pelton BK, Salo AC, Appleford DJ, Gilchrist C. Lymphocyte abnormalities in Behcet’s syndrome. Clin Exp Immunol 1980;42:175–85
179. Young C, Lehner T, Barnes CG. CD4 and CD8 cell responses to herpes simplex virus in Behcet’s disease. Clin Exp Immunol 1988;73:6–10
180. McDevitt HO. The HLA system and its relation to disease. Hosp Pract 1985;20(7):57–72
181. Strominger JL. Biology of the human histocompatibility leukocyte antigen (HLA) system and a hypothesis regarding the generation of autoimmune diseases. J Clin Invest 1986;77:1411–5
182. Ada GL, Rose NR. The initiation and early development of autoimmune diseases. Clin Immunol Immunopathol 1988;47:3–9
183. Norden CW, Kuller LH. Identifying infectious etiologies of chronic disease. Rev Infect Dis 1984;6:200–13
184. Slaughter L, Carson DA, Jensen FC, Holbrook TL, Vaughan JH. In vitro effects of Epstein–Barr virus on peripheral blood mononuclear cells from patients with rheumatoid arthritis and normal subjects. J Exp Med 1978;148: 1429–34
185. Tosato G, Steinberg AD, Yarchoan R, Heilman CA, Pike SE, De Seau V, Blaese RM. Abnormally elevated frequency of Epstein–Barr virus–infected B cells in the blood of patients with rheumatoid arthritis. J Clin Invest 1984;73:1789–95
186. Tosato G, Steinberg AD, Blaese RM. Defective EBV–specific suppressor T–cell function in rheumatoid arthritis. N Engl J Med 1981;305:1238–43
187. Bluestein HG, Hasler F. Epstein–Barr virus and rheumatoid arthritis. Survey of Immunology Research 1984;3:70–7
188. Venables P. Epstein–Barr virus infection and autoimmunity in rheumatoid arthritis. Ann Rheum Dis 1988;47:265–9
189. Elson CJ, Crawford DH, Bucknall RC, Allen C, Thompson JL, Epstein MA, Hall ND, Bacon PA. Infection with EB virus and rheumatoid arthritis. Lancet 1979;1:105
190. Venables PJW, Roffe LM, Erhardt CC, Maini RN, Edwards J.M.B., Porter AD. Titers of antibodies to RANA in rheumatoid arthritis and normal sera: relationship to Epstein–Barr virus infection. Arthritis Rheum 1981;24:1459–64
191. Rhodes G, Carson DA, Valbracht J, Houghten R, Vaughan JH. Human immune responses to synthetic peptides from the Epstein-Barr nuclear antigen. J Immunol 1985;134: 211–6
192. Venables PJW, Pawlowski T, Mumford PA, Brown C, Crawford DH, Maini RN. Reaction of antibodies to rheumatoid arthritis nuclear antigen with a synthetic peptide corresponding to part of Epstein–Barr nuclear antigen 1. Ann Rheum Dis 1988;47:270–9
193. Fuchs E, Hanukoglu I. Unraveling the structure of the intermediate filaments. Cell 1983;34:332–4
194. Fox RI, Chilton T, Rhodes G, Vaughan JH. Lack of reactivity of rheumatoid arthritis synovial membrane DNA with cloned Epstein Barr virus DNA probes. J Immunol 1986;137:498–501
195. Silverman SL, Schumacher HR. Antibodies to Epstein–Barr viral antigens in early rheumatoid arthritis. Arthritis Rheum 1981;24:1465–8
196. Musiani M, Zerbini M, Ferri S, Plazzi M, Gentilomi G, La Placa M. Comparison of the immune response to Epstein Barr virus and cytomegalovirus in sera and synovial fluids of patients with rheumatoid arthritis. Ann Rheum Dis 1987;46:837–42
197. Cohen BJ, Buckley MM, Clewley JP, Jones VE, Puttick AH, Jacoby RK. Human parvovirus infection in early rheumatoid and inflammatory arthritis. Ann Rheum Dis 1986;45:832–8
198. Anonymous. Arthritis and parvovirus infection [editorial]. Lancet 1985;1:436–8
199. Tingle AJ. One infectious agent – many syndromes. J Rheumatol 1987;14:653–5
200. Chantler JK, Tingle AJ, Petty RE. Persistent rubella infection associated with chronic arthritis in children. N Engl J Med 1985;313:1117–23
201. Chantler JK, Ford DK, Tingle AJ. Persistent rubella infection and rubella–associated arthritis. Lancet 1982;1:1323–5
202. Tingle AJ, Chantler JK, Pot KH, Paty DW, Ford DK. Postpartum rubella immunization: association with development of prolonged arthritis, neurological sequelae, and chronic rubella viremia. J Infect Dis 1985;152:606–12
203. Ford DK. One syndrome–many infectious agents [editorial]. J Rheumatol 1987;14:650–2
204. Wouters J.M.G.W., van der Veen J, van de Putte L.B.A., de Rooij D.-J. R.A.M. Adult onset Still’s disease and viral infections. Ann Rheum Dis 1988;47:764–7
205. Mann DL, Popovic M, Sarin P, Murray C, Reitz MS, Strong DM, Haynes BF, Gallo RC, Blattner WA. Cell lines producing human T–cell lymphoma virus show altered HLA expression [letter]. Nature 1983;305:58–60
206. Boumpas DT, Popovic M, Mann DL, Balow JE, Tsokos GC. Type C retroviruses of the human T cell leukemia family are not evident in patients with systemic lupus erythematosus. Arthritis Rheum 1986;29:185–8
207. Holoshitz J, Klajman A, Drucker I, Lapidot Z, Yaretzky A, Frenkel A, van Eden W, Cohen IR. T lymphocytes of rheumatoid arthritis patients show augmented reactivity to a fraction of mycobacteria cross–reactive with cartilage. Lancet 1986;2:305–9
208. Schwimmbeck PL, Yu D.T.Y., Oldstone M.B.A. Autoantibodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and Reiter’s syndrome. Molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease. J Exp Med 1987; 166:173–81
209. Shoenfeld Y, Isenberg D, eds. The mosaic of autoimmunity: factors associated with autoimmune condition. New York: Elsevier, 1989